16-29968051-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000279396.11(TMEM219):āc.382A>Gā(p.Ile128Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000251 in 1,614,132 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000279396.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM219 | NM_001083613.2 | c.382A>G | p.Ile128Val | missense_variant | 4/6 | ENST00000279396.11 | NP_001077082.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM219 | ENST00000279396.11 | c.382A>G | p.Ile128Val | missense_variant | 4/6 | 1 | NM_001083613.2 | ENSP00000279396.6 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000521 AC: 130AN: 249486Hom.: 1 AF XY: 0.000613 AC XY: 83AN XY: 135376
GnomAD4 exome AF: 0.000261 AC: 382AN: 1461828Hom.: 4 Cov.: 31 AF XY: 0.000347 AC XY: 252AN XY: 727226
GnomAD4 genome AF: 0.000151 AC: 23AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 08, 2023 | The c.382A>G (p.I128V) alteration is located in exon 4 (coding exon 3) of the TMEM219 gene. This alteration results from a A to G substitution at nucleotide position 382, causing the isoleucine (I) at amino acid position 128 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at